Chemistry: molecular biology and microbiology – Vector – per se
Patent
1998-08-18
2000-07-04
Bui, Phuong T.
Chemistry: molecular biology and microbiology
Vector, per se
4241851, 4241921, 4241931, 42419711, 4242031, 4242341, 4242561, 435 691, 435 693, 435 697, 530300, 530350, 536 237, A61K 39102, C07K 14285, C12N 1531
Patent
active
060837438
ABSTRACT:
Purified and isolated nucleic acid from specific strains of Haemophilus influenzae is provided which encodes at least a portion of the D15 outer membrane protein of Haemophilus. The nucleic acid is used to produce peptides, polypeptides and proteins free of contaminant associated with Haemophilus for purposes of diagnosis and medical treatment. Furthermore, the nucleic acid may be used in the diagnosis of Haemophilus infection. Antisera obtained following immunization with the nucleic acid D15 outer membrane protein or peptides also may be used for the purpose of diagnosis and medical treatment.
REFERENCES:
patent: 4888170 (1989-12-01), Curtis, III
patent: 5013664 (1991-05-01), Brodeur et al.
patent: 5194254 (1993-03-01), Barber et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5593972 (1997-01-01), Weiner et al.
patent: 5620896 (1997-04-01), Hermann et al.
Thomas, W. et al--Molecular Cloning of DNA Coding for Outer Membrane Proteins of Haemophilus Type b--Inf. and Imm. Jun. 1986, pp. 812-817.
Whalen, Robert G.--Emerging Infectious Diseases--vol. 2, No. 3--Jul.-Sep. 1996, pp. 168-175.
Roth, Jack A. et al--Journal of National Cancer Institute--vol. 89, No. 1, Jan. 1, 1997--pp. 21-40.
Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, Dec. 7, 1995. Orkin et al.
Thomas, W.R.--Infection and Immunity--vol. 58, No. 4, Apr. 1990, pp. 1909-1913.
O'Hagan, Clin. Pharmacokinet. vol. 22, No. 1, pp. 1-10 (1992).
Ulmer et al. Curr. Opin. Invest. Drugs. vol. 2, No. 9, pp. 983-989 (1993).
Berns, C.A. et al,--J. Mol. Biol. 11:476-490--(1965).
Carlone, G.M. et al--J. Clin. Microbiol. 24:330-331--(1986).
Smith, D.B. et al--Gene 67:31-40--(1988).
Harkness, R. et al,--J. Bacteriol. 174:2425-2430--(1992).
Hamel et al,--J. Med. Microbiol.--23:163-170 (1987).
Mills et al, Infect. Immun. 61:399-410 (1993).
Trinchieri, Immunology Today 14:335-338 (1993).
Hopp, T.P.--J. Immunol. Methods--88:1-18 (1986).
Zangwill et al, MMWR 42:1-15, (1993).
Loeb et al--Infect. Immun. 55:2612-2618--(1987).
Panezutti, Infect. Immun. 61:1867-1872--(1993).
Loeb, M.R. et al--Outer Membrane Protein Composition in Disease Isolates of Haemophilus Influenzae: Pathogenic and Epidemiological Implications--Inf. And Imm. Dec. 1980, pp. 709-717.
Barenkamp, S.J. et al--Subtyping Isolates of Haemophilus Influenzae Type b by Outer-Membrane Protein Profiles--J. of Inf Diseases, vol. 143, No. 5, May 1981.
Gulig, P.A. et al.--Antibody Response of Infants to Cell Surface-Exposed Outer Membrane Proteins of Haemophilus Infleunzae type b After Systemic Haemophilus Disease--Inf. And Imm, Jul. 1982, pp. 82-88.
Vachon V.--Transmembrane Permeability Channels across the Outer Membrane of Haemophilus Influenzae Type b--J. of Bacteriology, Jun. 1985, pp. 918-924.
Coglan, New Scientist, 25 No. 1995, pp. 14-15.
Chong Pele
Klein Michel
Loosmore Sheena
Sia Dwe Yuan Charles
Thomas Wayne
Bui Phuong T.
Connaught Laboratories Limited
LandOfFree
Haemophilus outer membrane protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Haemophilus outer membrane protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Haemophilus outer membrane protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1485314